The Paradigm of Huntington’s Disease: Therapeutic Opportunities in Neurodegeneration
AUTOR(ES)
Leegwater-Kim, Julie
FONTE
The American Society for Experimental NeuroTherapeutics
RESUMO
Summary: Despite a relatively small number of affected patients, Huntington’s disease (HD) has been a historically important disease, embodying many of the major themes in modern neuroscience, including molecular genetics, selective neuronal vulnerability, excitotoxicity, mitochondrial dysfunction, apoptosis, and transcriptional dysregulation. The discovery of the HD gene in 1993 opened the door to the mechanisms of HD pathogenesis. Multiple pathologic mechanisms have been discovered, each one serving as a potential therapeutic target. HD thus continues to serve as a paradigmatic disorder, with basic bench research generating clinically relevant insights and stimulating the development of therapeutic human trials.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=534918Documentos Relacionados
- Predictive testing for Huntington's disease: protocol of the UK Huntington's Prediction Consortium.
- Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
- Predictive testing for Huntington's disease: after the gene. The United Kingdom Huntington's Disease Prediction Consortium.
- Huntington's disease: the case for genetic modifiers
- Huntington's disease: visuomotor disturbance in patients and offspring.
